UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000012491
Receipt No. R000014619
Scientific Title Phase II study of a utility and the biomarker of the capecitabine plus cisplatin chemotherapy for the HER2-negative gastric cancer which is impossible of curative resection
Date of disclosure of the study information 2013/12/05
Last modified on 2019/12/13 15:19:15

No. Disposal Last modified on Item of update
1 Insert 2013/12/04 17:56:15
2 Update 2014/04/06 15:08:53 Acronym
Acronym
3 Update 2014/06/06 18:25:19 UMIN ID1
4 Update 2014/06/07 10:28:22 Key secondary outcomes
Key secondary outcomes
5 Update 2019/12/13 15:19:15 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of primary sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
Institutions


Contact us.